Nimorazole
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG |
|
ECHA InfoCard | 100.026.723 |
Chemical and physical data | |
Formula | C9H14N4O3 |
Molar mass | 226.23 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
Nimorazole (INN) is a nitroimidazole anti-infective.[1] It is also being investigated for the treatment of head and neck cancer.[2][3]
References
- ↑ Roy, R. B.; Laird, S. M.; Heasman, L. (1975). "Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole". The British Journal of Venereal Diseases. 51 (4): 281–284. PMC 1046566 . PMID 1098732.
- ↑ Henk, J. M.; Bishop, K.; Shepherd, S. F. (2003). "Treatment of head and neck cancer with CHART and nimorazole: Phase II study". Radiotherapy and Oncology. 66 (1): 65–70. PMID 12559522. doi:10.1016/S0167-8140(02)00284-0.
- ↑ Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov
Entamoeba |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acanthamoeba | |||||||||||||||||
|
ER |
| ||||||
---|---|---|---|---|---|---|---|
GPER |
| ||||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.